LivaNova PLC (LIVN) Offers Update Following FDA Warning Letter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
LivaNova PLC Provides Update on FDA Warning Letter
January 5, 2016 2:15 PM ESTLONDON, Jan. 05, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ: LIVN) (LSE: LIVN) (the Company) received a Warning Letter dated December 29, 2015, from the United States Food and Drug Administration (FDA) alleging certain violations of FDA regulations applicable to medical device manufacturers at its Munich, Germany and Arvada, Colorado facilities.
The Company currently believes that less than 1 percent of 2016 consolidated sales could be impacted by this Warning Letter, and that FDAs concerns can be resolved without a material impact on the Companys financial results. Â Further... More
